Tuesday - April 1, 2025
Alzheimer's Association Statement on European Medicines Agency Negative Opinion on Kisunla(R) for the Treatment of Alzheimer's Disease
March 29, 2025
CHICAGO, Illinois, March 29 [Category: Health Care] -- The Alzheimer's Association posted the following news release on March 28, 2025:

* * *

Alzheimer's Association Statement on European Medicines Agency Negative Opinion on Kisunla(R) for the Treatment of Alzheimer's Disease

The Alzheimer's Association is disappointed by today's decision by the European Medicines Agency (EMA) to recommend against allowing Kisunla(R) (donanemab) to . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products